In Vivo Hematopoietic Stem Cell Gene Therapy for SARS-CoV2 Infection Using a Decoy Receptor

While SARS-CoV2 vaccines have shown an unprecedented success, the ongoing emergence of new variants and necessity to adjust vaccines justify the development of alternative prophylaxis and therapy approaches. Hematopoietic stem cell (HSC) gene therapy using a secreted CoV2 decoy receptor protein (sAC...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hongjie, Li, Chang, Obadan, Adebimpe O., Frizzell, Hannah, Hsiang, Tien-Ying, Gil, Sucheol, Germond, Audrey, Fountain, Connie, Baldessari, Audrey, Roffler, Steve, Kiem, Hans-Peter, Fuller, Deborah H., Lieber, André
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063208/
https://www.ncbi.nlm.nih.gov/pubmed/35057635
http://dx.doi.org/10.1089/hum.2021.295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063208/
https://www.ncbi.nlm.nih.gov/pubmed/35057635
http://dx.doi.org/10.1089/hum.2021.295

Ejemplares similares